DFTX
Definium Therapeutics, Inc.Healthcare$20.68
▲ Bullish
Mkt Cap: $2.06B|Float: 93.7M|SI: 16.0%|DTC: 9.5
Data as of market close Apr 2, 2026
IV Rank
100
IV Pctl
89%
HV 20d
5792.0%
52W Range
$5-$21
ATR(14)
$1.13
Exp. Move
±4.7%
P/C Ratio
0.16
Earnings
May 7
GEX Positive
DEX Long
Net Call Premium
IV High
Max Pain Below
Exp. Move Wide
Low Put/Call
DFTX Key Options Data
- IV Rank
- 100%
- Total GEX
- $0.00B
- Total DEX
- $2.4M
- Max Pain
- $18.00
- Expected Move
- ±4.7%
- Put/Call OI
- 0.16
- Net Premium
- $0.4M
- Spot Price
- $20.68
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-17 | 15 | ±$0.97 | ±4.7% | $19.71 | $21.66 |
| 2026-05-15 | 43 | ±$4.57 | ±22.1% | $16.11 | $25.26 |
| 2026-06-18 | 77 | ±$4.25 | ±20.6% | $16.43 | $24.93 |
| 2026-07-17 | 106 | ±$5.30 | ±25.6% | $15.38 | $25.98 |
| 2026-09-18 | 169 | ±$6.85 | ±33.1% | $13.83 | $27.53 |
| 2027-01-15 | 288 | ±$16.35 | ±79.1% | $4.33 | $37.03 |
Explore DFTX options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.